0000899243-19-005560.txt : 20190301
0000899243-19-005560.hdr.sgml : 20190301
20190301200153
ACCESSION NUMBER: 0000899243-19-005560
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190301
DATE AS OF CHANGE: 20190301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUY GEOFFREY W DR
CENTRAL INDEX KEY: 0000941388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 19651463
MAIL ADDRESS:
STREET 1: ETHICAL HOLDINGS PLC CORPUS CHRISTI
STREET 2: HOUSE 9 WEST STREET GODMANCHESTER
CITY: CAMBRIDGESHIRE PE18
STATE: A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-01
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0000941388
GUY GEOFFREY W DR
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
1
1
0
0
Executive Chairman
Ordinary Shares
2019-03-01
4
S
0
126972
14.29
D
8914549
D
Ordinary Shares
2019-03-01
4
S
0
223512
14.36
D
8691037
D
Ordinary Shares
2019-03-01
4
S
0
213480
14.44
D
8477557
D
Ordinary Shares
2019-03-01
4
S
0
12036
14.50
D
8465521
D
These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
The price reported in Column 4 is a weighted average price per ordinary share ($171.47 per ADS). These shares were sold in multiple transactions at prices ranging from $170.74 per ADS (or $14.23 per ordinary share) to $171.73 per ADS (or $14.31 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($172.37 per ADS). These shares were sold in multiple transactions at prices ranging from $171.75 per ADS (or $14.31 per ordinary share) to $172.72 per ADS (or $14.39 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($173.27 per ADS). These shares were sold in multiple transactions at prices ranging from $172.77 per ADS (or $14.40 per ordinary share) to $173.76 per ADS (or $14.48 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($173.98. per ADS). These shares were sold in multiple transactions at prices ranging from $173.80 per ADS (or 14.48 per ordinary share) to $174.06 per ADS (or $14.51 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Geoffrey W. Guy
2019-03-01